6th Digital Health Conference | Barcelona 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Digital Health Conference | Barcelona 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
6th Digital Health Conference | Barcelona 2026
About This Event
The 6th Digital Health Conference will take place on to at the Hotel Catalonia Plaza Catalunya in Barcelona, Spain. This exclusive medium-sized conference brings together leaders from the pharma, MedTech, and health tech industries to explore the transformative impact of digital health solutions.
Key themes include artificial intelligence in healthcare, patient-centric innovation, regulatory trends, digital therapeutics (DTx), and the role of digital health in drug development. The event features insights from global experts, networking opportunities, and collaborative discussions shaping the future of healthcare.
Venue
Hotel Catalonia Plaza CatalunyaCarrer de Bergara, 11
Eixample, 08002 Barcelona
Spain
Who Attends
- Digital health and MedTech leaders
- Pharmaceutical industry executives
- Regulatory affairs professionals
- Health tech investors and innovators
- Digital Therapeutics (DTx) and DiGA experts
- Startup founders and scale-up leaders
- Healthcare policymakers and academics
Key Focus Areas
- AI and Data-Driven Healthcare in Pharma
- Digital Health and Patient-Centric Innovation
- Regulatory Trends in Digital Medicine and DTx
- Digital Health's Role in Drug Development
- Pharma & Healthcare Ecosystem Collaboration
- Digital Transformation in Pharma Operations
- Impact of Digital Biomarkers in Neuroscience
- AI Coaching for Longevity and 4P Medicine
Event Highlights
- 16+ TOP Pharma Keynotes
- 2 Stand-Up Discussions
- Cocktail Night Networking
- Networking Lunches & Coffee Breaks
- Exclusive Networking App
- 40-Minute Presentations with Q&A
Featured Speakers
- Irenee Colin – Digital Health Director, Integrated Health Solutions
- Ghaith Sankari – Director, Digital Health
- Alexandra Kalpadaki-Smith – Associate Director, Digital Science
- Jesus Buso-Cortes – Head of Marketing, Digital Health Solutions (EMEA)
- Mark Phillip Loria – Associate Director, Lead Solution Architect
- Katarina Kulkova – Sr. Product Manager
- Richard Hutson – Digital Health Lead
- Gurpreet Chowdhry – Digital Health Asset Lead
- Roberto Strino – AI Translator and Digital Health Innovation Manager
- Lyuba Kolos – Business Leader, Digital Health (Western Europe)
- Alexander Wermuth – Global Program Lead, Digital Health Solutions
- Rubén Pareja Bailón – Sales Manager, DHS
Registration & Pricing
| Ticket Type | Price | Inclusions |
|---|---|---|
| Super Early Bird | €590 | 2 Days Full Ticket, 16+ Pharma Keynotes, Networking Events, Exclusive App |
| Early Bird (June) | €790 | 2 Days Full Ticket, 16+ Pharma Keynotes, Networking Events, Exclusive App |
| July | €1090 | 2 Days Full Ticket, 16+ Pharma Keynotes, Networking Events, Exclusive App |
| August | €1290 | 2 Days Full Ticket, 16+ Pharma Keynotes, Networking Events, Exclusive App |
| October | €1590 | 2 Days Full Ticket, 16+ Pharma Keynotes, Networking Events, Exclusive App |
Industry Innovators & Sponsors
- Silver Sponsors: [List company names from official content]
- Bronze Sponsor: [List company names from official content]
- Valuable Partners: [List partners from official content]
Contact Us
- Program & Operations:
📞 +421 902 161 667
✉️ vladka.roriz@ubiqevents.com - Sponsorship Opportunities:
📞 +351 926 623 972
✉️ andre.prado@ubiqevents.com
Organized by UBIQ events, s. r. o. – A life sciences-focused events provider.
Register Now
Secure your participation in the 6th Digital Health Conference by registering through the official website. Limited seats available for this exclusive event.
REGISTER NOWData sheet
6th Digital Health Conference | Barcelona 2026 – Event Attendee & Buyer Profile Analysis
Event date: 3–4 November 2026
Location: Hotel Catalonia Plaza Catalunya, Barcelona, Spain
Event status: Upcoming
Research date: 30 June 2026
Event Overview
| Event Name | 6th Digital Health Conference | Barcelona 2026 |
| Event Date | 3–4 November 2026 |
| Event Status | Upcoming |
| Venue | Hotel Catalonia Plaza Catalunya |
| City | Barcelona |
| State / Region | Catalonia |
| Country | Spain |
| Organizer | UBIQ events, s. r. o. (confirmed on official event website) |
| Official Event Website | digitalhealthconference.net |
| Event Type | B2B conference / summit |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | IT & Technology |
| Audience Reach | Global, with likely strongest concentration from Europe and multinational life sciences organizations |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Low for headcount; official site confirms format, themes, venue, dates, and speaker volume, but not total attendee count |
| Main Purpose of Event | To connect pharma, MedTech, digital health, regulatory, investor, and health tech leaders around AI, patient-centric innovation, digital therapeutics, digital medicine, clinical development, and pharma digital transformation. |
About the Event
The 6th Digital Health Conference | Barcelona 2026 is a two-day B2B life sciences conference focused on the intersection of digital health, MedTech, and the pharmaceutical industry. According to the official event website, the 2026 edition will cover artificial intelligence in healthcare, real-world data, patient-centric innovation, regulatory developments in digital medicine and DTx, drug development, clinical trials, and digital transformation in pharma operations.
This event matters because it is positioned as an executive-level networking and knowledge exchange forum rather than a mass-market expo. The official attendee and speaker profile indicates relevance for commercial teams targeting pharma digital leaders, health tech innovators, digital therapeutics stakeholders, regulatory specialists, investors, and partnership decision-makers. For lead generation, the strongest value lies in account-based outreach to life sciences and digital health decision-makers, though public attendee-list visibility appears limited.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Pharma digital health leaders | Global and regional pharmaceutical companies | High influence over digital programs, patient engagement, clinical innovation, and vendor evaluation | Core audience for software, AI, data, digital therapeutics, and service providers |
| MedTech executives and product leaders | Medical device and connected care companies | Decision influence on digital products, interoperability, remote monitoring, and commercialization | Relevant for digital platforms, data tools, device partnerships, and patient pathway solutions |
| Digital therapeutics and DiGA specialists | DTx vendors, digital medicine businesses, reimbursement-focused innovators | Strong influence in clinical evidence, regulatory readiness, and market access partnerships | Important for suppliers offering regulatory, evidence-generation, engagement, and commercialization support |
| Regulatory affairs professionals | Pharma, MedTech, DTx, compliance, and advisory organizations | Gatekeepers for approval pathways, risk controls, and compliant digital deployment | High relevance for vendors selling validation, quality, privacy, and regulatory strategy services |
| Clinical development and trial innovation teams | Drug development, clinical operations, and translational medicine groups | Influence over digital biomarkers, decentralized trial tools, patient data capture, and RWE solutions | Relevant for trial technology vendors, analytics platforms, and digital endpoint providers |
| Health tech investors | Venture capital, strategic investors, corporate innovation units | Capital allocation and partnership influence | Useful for startup fundraising, commercial introductions, and ecosystem partnerships |
| Startup founders and scale-up leaders | Digital health startups, software innovators, platform vendors | Active buyers of channel access, partnerships, data tools, and growth services | Relevant for acceleration, integration, compliance, and GTM support suppliers |
| Healthcare policymakers and academics | Public health bodies, universities, research institutions | Thought leadership and ecosystem influence more than direct procurement | Useful for pilots, evidence generation, policy alignment, and credibility building |
| Partnership and business development teams | Pharma, MedTech, digital health, and solution providers | Strong influence over alliances, licensing, and commercial collaboration | High-value targets for strategic partnerships and channel relationships |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Barcelona | Local digital health ecosystem, hospitals, innovation hubs, and regional business visitors | Medium | Strong host-city appeal for meetings, networking, and European conference travel |
| Catalonia | Regional life sciences, MedTech, and research stakeholders | Medium | Likely source of health innovation and academic attendees |
| Spain | National pharmaceutical, digital health, and healthcare industry participants | Medium to High | Domestic attendance is likely, but the official positioning is broader than a Spain-only event |
| Western Europe | Pharma, MedTech, DTx, and digital medicine leaders from EU and UK markets | High | Strongest likely buyer pool based on event topics and European regulatory relevance |
| EMEA | Regional commercial and program leaders serving Europe, Middle East, and Africa | Medium to High | Supported by speaker role references that include EMEA and Western Europe responsibilities |
| Global multinational life sciences hubs | International pharma, MedTech, investors, and health tech innovators | Medium | Official site describes global experts and industry leaders, but no country-level attendee breakdown is publicly confirmed |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official event language references global experts, pharma leaders, MedTech leaders, regulators, investors, and health tech pioneers. Topic relevance extends beyond Spain and supports international executive participation. |
| Regional | Secondary practical concentration | The likely highest density of accessible buyers is European, especially Western Europe and EMEA-facing life sciences teams. |
4. Sample Buyer Companies and Websites
The verified official source provided for this report does not publicly list named current-year attendee companies, sponsor companies, exhibitor companies, or a buyer directory. Prior-year participation evidence is referenced on the site, but the copied source text does not disclose company names. The table below therefore preserves a strict verification standard and avoids unsupported attendance claims.
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Current-year buyer company directory not publicly disclosed by organizer in verified source | Not publicly confirmed | Official content confirms target personas such as pharma leaders, MedTech leaders, regulators, investors, and health tech pioneers, but not named organizations. | digitalhealthconference.net | Digital Health Director; VP Digital Health; Director Clinical Innovation; Regulatory Affairs Director; Partnerships Director | Confirmed Current-Year Participant |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Digital Health Director | Digital Health / Innovation | Director | Core decision-maker for digital health strategy, solution pilots, and ecosystem partnerships |
| 2 | VP / Head of Digital Health | Executive / Innovation | VP / Head | Typically owns roadmap, budgets, partnerships, and executive sponsorship |
| 3 | Associate Director, Digital Science | R&D / Digital Science | Director | Relevant for data-driven development, translational innovation, and evidence-generation tools |
| 4 | Clinical Innovation Director | Clinical Development / Medical Affairs | Director | Important for digital endpoints, remote patient engagement, and trial modernization |
| 5 | Regulatory Affairs Director / Manager | Regulatory / Compliance | Manager to Director | Key for digital medicine, DTx, software validation, and compliant market entry |
| 6 | Product Manager / Senior Product Manager | Product | Manager / Senior Manager | Relevant for feature evaluation, market adoption, and workflow integration |
| 7 | AI Innovation Manager | AI / Data / Innovation | Manager | High relevance because AI is a headline topic of the conference |
| 8 | Business Development Director | Business Development / Partnerships | Director | Important for alliances, channel agreements, and co-development conversations |
| 9 | Partnerships Director | Strategic Partnerships | Director | Useful where ecosystem collaboration and platform integration are required |
| 10 | Investor / Principal / Partner | Investment | Senior | Relevant for startup funding, growth-stage relationships, and strategic introductions |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Officially central to the event positioning | Digital health strategy, patient engagement, RWE, and digital trial enablement |
| 2 | Medical Devices | MedTech leaders are a named audience group | Connected devices, remote monitoring, software-enabled care pathways |
| 3 | Hospital & Health Care | Relevant for provider-side adoption and patient experience initiatives | Care delivery tools, digital workflows, and patient pathway transformation |
| 4 | Biotechnology | Relevant to innovation-led life sciences teams and digital development environments | Clinical data, digital biomarkers, and trial acceleration |
| 5 | Information Technology & Services | Supports digital transformation, integration, and implementation services | Systems integration, managed services, and digital modernization |
| 6 | Computer Software | Core fit for digital health platforms, analytics, and AI applications | SaaS, engagement platforms, clinical software, and analytics |
| 7 | Health, Wellness & Fitness | Relevant to patient-centric digital solutions and preventive care models | Engagement apps, coaching, adherence, and digital behavior support |
| 8 | Research | Academic and evidence-generation attendees are relevant | Clinical research collaboration and validation studies |
| 9 | Venture Capital & Private Equity | Investors are named in the attendee mix | Funding, partnerships, and strategic growth conversations |
| 10 | Medical Practice | Relevant where clinicians and medical decision-makers influence solution adoption | Practice workflow tools, digital diagnostics, and patient management support |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Attendance figure not publicly confirmed by the organizer. | Unconfirmed | Official website content reviewed | No published attendee headcount in verified source |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Official website content reviewed | Event appears conference-led rather than a large expo; sponsorship exists but exhibitor volume is not disclosed |
| Buyer count | Not publicly confirmed | Unconfirmed | Official website content reviewed | No buyer directory or registration segment breakdown available in verified source |
| Speaker count | 16+ top pharma keynotes | Confirmed | Ticket pricing section on official website | The website also notes that new speakers will be disclosed in the coming days |
| Stand-up discussion sessions | 2 | Confirmed | Ticket pricing section on official website | Useful indicator of curated networking structure |
| Historical attendance | Not publicly confirmed in provided source | Historical / prior-year evidence unavailable | Official website content reviewed | Past event reference is present, but no numeric history is shown in the copied source text |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| AI in healthcare and pharma | Operational efficiency, patient insights, analytics, and decision support | AI platform demos, proof-of-concept discussions, and innovation partnerships | AI software, data science services, predictive analytics, workflow automation |
| Patient-centric innovation | Better adherence, engagement, and patient experience outcomes | Pilot discussions with digital health, medical affairs, and product teams | Engagement apps, remote support tools, digital companion solutions |
| Regulatory trends in digital medicine and DTx | Compliance readiness, documentation, quality systems, market access alignment | Advisory-led discussions with regulatory and compliance leaders | Regulatory consulting, quality management, validation, privacy and security services |
| Drug development and clinical trials | Digital endpoints, patient recruitment, data capture, real-world evidence | Clinical innovation and partnership meetings | Clinical software, biomarkers, trial tech, RWE platforms |
| Pharma operations digital transformation | Modernized workflows, system integration, scalable digital processes | Enterprise solution and implementation conversations | SaaS, integration, automation, cloud, data architecture support |
| Pharma and healthcare ecosystem collaboration | Partnership sourcing, co-development, channel access, interoperability | Business development and alliance meetings | Partner enablement, integration support, strategic consulting |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | High | The event is tightly aligned to digital health, pharma, MedTech, and innovation decision-makers. |
| Decision-maker availability | High | Speaker and attendee positioning suggests director-level and executive participation rather than junior-only attendance. |
| Data collection potential | Medium | Strong networking value, but public attendee list visibility is limited in the verified source. |
| Apollo targeting potential | Very High | The event maps well to precise Apollo industry, department, and seniority filters across life sciences and health tech. |
| Geographic targeting potential | High | Barcelona provides a useful anchor, but the practical buyer universe is broader across Spain, Western Europe, and EMEA. |
| Best outreach approach | High | ABM-style outreach to digital health, innovation, clinical, regulatory, and partnership leaders is the most effective route. |
| Overall lead quality | High | Strong fit for specialized B2B healthcare, software, data, compliance, and partnership sellers. |
| Best use case | High | Best suited for account-based outreach, event-led prospecting, sponsorship targeting, and executive meeting generation. |
| Limitations / risks | Medium | Publicly confirmed named attendee organizations are limited in the verified source, reducing direct attendee-list building confidence. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals; Medical Devices; Hospital & Health Care; Biotechnology; Information Technology & Services; Computer Software; Health, Wellness & Fitness; Research; Venture Capital & Private Equity; Medical Practice | Build a digital health-focused account universe around life sciences and supporting technology buyers |
| Departments | Innovation; Product; Clinical; Medical Affairs; Regulatory; Information Technology; Business Development; Partnerships; Strategy; Operations; R&D | Narrow outreach to functions directly aligned with event topics and likely purchasing influence |
| Seniority | C-Level; VP; Head; Director; Senior Manager; Manager | Focus on strategic and budget-holding roles while retaining operational evaluators |
| Job titles | Digital Health Director; VP Digital Health; Head of Digital Innovation; Director Clinical Innovation; Director Digital Medicine; Regulatory Affairs Director; Senior Product Manager; AI Innovation Manager; Director Partnerships; Business Development Director; Medical Affairs Director; Clinical Operations Director | Mirror the event’s executive and topic profile |
| Geography | Spain; Catalonia; United Kingdom; Germany; France; Netherlands; Switzerland; Belgium; Nordics; broader EMEA | Prioritize the most plausible attendance and partnership corridors for a Barcelona-based digital health event |
| Employee size | 51–200; 201–500; 501–1,000; 1,001–5,000; 5,001–10,000; 10,001+ | Covers venture-backed scale-ups through multinational life sciences groups |
| Keywords | digital health; digital therapeutics; DTx; DiGA; digital medicine; patient engagement; real-world data; clinical trials; digital biomarkers; AI healthcare; pharma innovation; remote monitoring | Find organizations and contacts aligned to the published conference agenda |
| Technologies, if relevant | AI / machine learning; clinical data platforms; patient engagement platforms; remote monitoring; analytics; cloud healthcare systems | Useful for solution-led prospecting into digital transformation buyers |
| Revenue range, if relevant | Mid-market to enterprise; prioritize companies with innovation budgets and active partnership programs | Improves conversion quality for premium digital health solutions |
| Company type | Public companies; private companies; PE/VC-backed growth companies; strategic healthcare innovators | Supports both enterprise and innovation-led buyer targeting |
Suggested Apollo Search Logic: ("digital health" OR "digital medicine" OR DTx OR DiGA OR "patient engagement" OR "real-world data" OR "digital biomarkers" OR "clinical innovation" OR "AI healthcare") AND (Pharmaceuticals OR Medical Devices OR Biotechnology OR Hospital & Health Care OR Computer Software) AND (Director OR Head OR VP OR C-Level).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| 6th Digital Health Conference | Barcelona 2026 Official Website | Official event website | Event title, dates, venue, city, country, agenda themes, attendee profile, speaker positioning, ticket inclusions, and organizer contact details | High |
| Official website speaker and topics sections | Official agenda / speaker content | Named seniority profile of speakers, 16+ top pharma keynote claim, AI and digital health topic emphasis, and likely buyer functions | High |
| Official website contact / organizer section | Organizer information | Organizer name reference: UBIQ events, s. r. o.; sponsorship and operations contact details | High |
Verification note: This report intentionally avoids naming attendee or buyer companies not explicitly disclosed in the verified official source. The event appears suitable for B2B prospecting and Apollo.io targeting, but public attendee-list building value is constrained by limited named participant disclosure.
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 6th Digital Health Conference | Barcelona 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds